Piramal Pharma Ltd.PPLPHARMAWatchMajormateriality 79 out of 100
Acquisition announced
M&Aacquisition
As filed
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Acquisition of Kenalog®, a branded commercial injectable product
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.